本页面由Tiger Trade Technology Pte. Ltd.提供服务

Mineralys Therapeutics, Inc.

20.53
-1.7000-7.65%
成交量:191.67万
成交额:4,061.74万
市值:18.10亿
市盈率:-4.69
高:22.82
开:22.04
低:20.41
收:22.23
52周最高:47.65
52周最低:20.41
股本:8,815.85万
流通股本:6,602.58万
量比:2.27
换手率:2.90%
股息:- -
股息率:- -
每股收益(TTM):-4.3763
每股收益(LYR):-2.2900
净资产收益率:-80.88%
总资产收益率:-46.18%
市净率:3.29
市盈率(LYR):-8.97

数据加载中...

2026/06/30

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/06/29

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/06/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/06/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/06/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/06/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/06/10

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/06/03

重要事件披露

Form 8-K - Current report
2026/06/03

重要事件披露

Form 8-K - Current report
2026/05/22

重要事件披露

Form 8-K - Current report
2026/05/19

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/05/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/05/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/05/11

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/05/06

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/05/06

重要事件披露

Form 8-K - Current report
2026/04/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/04/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/04/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/04/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities